Zoekresultaten - 3 results
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Vaccines Electronic Health Records Europe European Union Female Hospitalization Humans Male Retrospective Studies SARS-CoV-2 Vaccination Vaccine Efficacy Abstract: Using a common protocol across seven ...
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
COVID-19 booster (vs complete primary vaccination), we performed monthly Cox regression models using retrospective cohorts constructed from electronic health registries in eight European countries, October ...
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Susana; VEBIS-EHR working group Source: Expert Rev Vaccines, Volume 23, Issue 1 (2024) Keywords: Aged Aged, 80 and over Cohort Studies COVID-19 COVID-19 Vaccines Electronic Health Records Europe Female ...